Chemotherapy-induced Neuropathy Clinical Trial
Official title:
Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies
Chimiotherapy produces neuropathies injuries to 30% to 70% cases. A third of those patients keeps suffering from this side effects disabilities and their quality of life is seriously affected. Hypnosis, as a non-invasive tool without physical side effects, might be used to relieve them. the purpose of this trial based on our own experience, is to demonstrate the value of using hypnosis and self-hypnosis in chimiotherapy- induced chronic neuropathies. The aim will be to sustainably improve the quality of life by expanding self-management of pain and motor function side effect.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04920097 -
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
|
N/A | |
| Completed |
NCT01557608 -
Characterization and Treatment of Chemotherapy Neuropathy
|
N/A |